(SigmaQuest: Sunnyvale, CA) -- SigmaQuest Inc., the leader of on-demand, scalable solutions for product quality management, and Wilson Sonsini Goodrich & Rosati, a provider of legal services to technology, life sciences, and growth enterprises worldwide, are hosting a free webinar titled, "What Medical Device Companies Should Know About Product Liability and Recalls: An Overview and Tips for Reducing Risks" on Aug. 18 at 9 a.m. PDT.

This is a must-attend event for companies building FDA-regulated products. There is no charge to participate, but preregistration is required.

The webinar will cover the effect of product quality issues and liability, how to handle recalls and better yet, avoid them. Attendees will also get insight into the drain on companies as a result of product defects and what this means in terms of litigation, lost time, and dollars in defending and overcoming bad publicity. In addition, attendees will learn how to avoid product liability, minimize exposure in contractual matters, properly communicate product safety information and ensure regulatory compliance.

To register for the webinar, visit www1.gotomeeting.com/register/871537440.

Featured speakers

• David Hoffmeister is a partner at Wilson Sonsini Goodrich & Rosati, where he plays a major leadership role in the firm's drug and device regulatory and health care law practice within the life sciences practice. He brings more than 20 years of experience in drug and device regulatory and health care law to the firm. He represents pharmaceutical, biotechnology, medical device, diagnostic, and dietary supplement clients, advising them on a variety of regulatory and health care issues, such as strategies for obtaining FDA product approvals and clearances, recalls, labeling, and claim support for advertising and promotional materials. Before joining Wilson Sonsini Goodrich & Rosati, Hoffmeister was senior counsel for drug and device law at Syntex Corp. where his primary focus was advising senior management on worldwide issues affecting the ability of the corporation and its affiliates to develop, manufacture, and distribute pharmaceutical, device, diagnostic, and over-the-counter drugs in compliance with the Federal Food, Drug, and Cosmetics Act, as well as implementing regulations and applicable state and federal health care laws.

• Jon Nygaard an attorney for Wilson Sonsini Goodrich & Rosati's life sciences practice, has three decades of legal experience in drug and device regulatory and health care law. Nygaard assists clients in managing the regulatory aspects of developing and testing products, obtaining FDA approval or clearance to market them, complying with post-marketing requirements, and meeting the challenges of competitors. Nygaard has also served as vice president and general counsel of the endovascular solutions division of Guidant Corp. and was in the law department at Syntex Corp. for 14 years. He has a juris doctor degree from Santa Clara University School of Law, a master's of science degree from Butler University and a bachelor's of art degree from Yale University.

• Nader Fathi has served as CEO of SigmaQuest for the past seven years. During this tenure, he has overseen the development of best-in-class product quality management software and has collaborated with numerous, renowned medical device and electronics-based companies to help them attain optimal product quality. Prior to SigmaQuest, Fathi was vice president of worldwide sales operations and emerging markets at IKOS Systems. Prior to IKOS, he held a number of leadership positions at Cadence Design Systems. Before this, he held various management positions with Dazix (an Intergraph company) and Xerox Microelectronics. He has a bachelor of science and a master of science in electrical engineering from University of Southern California and a business management certificate from UCLA Anderson Graduate School of Management.